Oliver Kiddie – Managing Director – Legend Mining (ASX:LEG) is an Australian exploration company listed on the Australian Securities Exchange (ASX:LEG). Legend’s mission is to make value-adding mineral discoveries and utilise all available asset bases to maximise stakeholder benefit.
Copyright 2024 – Finance News Network
24 Mar 2021 - Shaw and Partners Chief Investment Officer Martin Crabb discusses historical precedence for recovering from government spending, the possible rise of interest rates, labour market data, and investment strategies in this environment.
24 Oct 2019 - BluGlass Limited (ASX:BLG) Managing Director and CEO, Giles Bourne, discusses the launch of the company's new laser diode business and how this fits into its strategy.
06 Nov 2019 - Immutep Limited (ASX:IMM) CEO, Marc Voigt provides an update on the company's clinical trial data for its Phase 1 trial in melanoma, TACTI-mel, where patients are responding positively to the combination therapy of efti and Keytruda.
21 Mar 2021 - Elixinol Global (ASX:EXL) CEO, Oliver Horn talks about its proposed acquisition of CannaCare Health GmbH (CannaCare) one of Germany’s leading CBD (Cannabidiol) brands following the down scheduling of CBD in Europe late last year in what the Company sees as highly strategic opportunity and important pathway to profitability.
27 May 2024 - Peter Barrett discusses how Australia can lead in quantum computing and AI by leveraging local talent, resources, and capital to build transformative companies and retain innovation.
26 Feb 2021 - Anteris Technologies Limited (ASX:AVR) CEO & Managing Director Wayne Paterson talks about the benefits of the company's Anteris DurAVR aortic replacement valve to work better and for longer, company strategy and goals for 2021.
11 Mar 2020 - Immutep Limited (ASX:IMM) CEO, Marc Voigt provides an update on the company's 1H20 results, including data from its clinical trials, collaborations with major pharma and outlook for the second half.
06 Sep 2023 - Daniel Ortisi, Equity Research Analyst at Stock Doctor, discusses the winners and losers from reporting season and gives advice on portfolio positioning for FY24.